16 results
8-K
EX-2.3
ADIL
Adial Pharmaceuticals Inc
21 Sep 23
Entry into a Material Definitive Agreement
4:10pm
and customer and supplier lists and information), (g) other intellectual property rights, and (h) copies and tangible embodiments thereof (in whatever
POS AM
ADIL
Adial Pharmaceuticals Inc
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
impact our key clinical trial vendors and supplier of our active pharmaceutical ingredient. The full extent to which the COVID-19 pandemic impacts
POS AM
ADIL
Adial Pharmaceuticals Inc
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
of capital, increase loss of work time from key personnel, and negatively impact our key clinical trial vendors and supplier of our active pharmaceutical
POS AM
v4jfhrpe4aqcps9cy9
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
2cybmkf03 qknkqe
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
8-K
EX-10.1
3cmu2bpe32topbq
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
POS AM
yqlt00e oi9m
22 Apr 20
Prospectus update (post-effective amendment)
5:05pm
POS AM
mxqvbi
22 Apr 20
Prospectus update (post-effective amendment)
5:04pm
- Prev
- 1
- Next